Viewing Study NCT02680951


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-02-20 @ 8:19 PM
Study NCT ID: NCT02680951
Status: WITHDRAWN
Last Update Posted: 2018-04-19
First Post: 2016-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia
Sponsor: Emory University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pediatric View
None Adolescent View